Utilizing recently published massively multiplexed scRNA-seq datasets, we evaluated lncRNA expression following treatment with p53-activating idasanutlin (Nutlin-3 derivative) in 24 diverse cancer cell lines (54). Here, TP53 is linked to cancer.